Oncotarget

Vol 2, No 7

July 2011

View Archive »

Order a Reprint

About The Cover

PKM2 contributes to metabolic reprogramming and cancer progression by serving as a PHD3-dependent coactivator for HIF-1. Prolyl hydroxylation of PKM2 by PHD3 promotes the interaction of PKM2 with HIF-1α, thereby stabilizing HIF-1 binding to the HRE of target genes, recruitment of coactivator p300, histone acetylation, and subsequent transcription of HIF-1 target genes, which encode proteins that are involved in metabolic reprogramming, angiogenesis, and many other critical aspects of cancer progression. See Luo and Semenza.

Table of Contents

Editorial

Allogeneic adoptive cell transfer therapy as a potent universal treatment for cancer

Allogeneic adoptive cell transfer therapy as a potent universal treatment for cancer

https://doi.org/10.18632/oncotarget.300

Assaf Marcus,  and Zelig Eshhar
525-526
Abstract  |  PDF  |  HTML  |  Order a Reprint

Editorial Comments

Paracrystals of STAT proteins and their dissolution by SUMO: How reduced transcription factor solubility increases cytokine signaling

Paracrystals of STAT proteins and their dissolution by SUMO: How reduced transcription factor solubility increases cytokine signaling

https://doi.org/10.18632/oncotarget.307

Mathias Droescher, Andreas Begitt,  and Uwe Vinkemeier
527-528
Abstract  |  PDF  |  HTML  |  Order a Reprint

Research Papers

A breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variables

A breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variables

https://doi.org/10.18632/oncotarget.298

David Endesfelder, Nicholas McGranahan, Nicolai Juul Birkbak, Zoltan Szallasi, Maik Kschischo, Trevor Graham,  and Charles Swanton
529-537
Abstract  |  PDF  |  HTML  |  Order a Reprint

Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy

Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy

https://doi.org/10.18632/oncotarget.302

Melissa L. Sokolosky, Kristin M. Stadelman, William H. Chappell, Stephen L. Abrams, Alberto M. Martelli, Franca Stivala, Massimo Libra, Ferdinando Nicoletti, Lyudmyla B. Drobot, Richard A. Franklin, Linda S. Steelman,  and James A. McCubrey
538-550
Abstract  |  PDF  |  HTML  |  Order a Reprint

Research Perspectives

Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells

Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells

https://doi.org/10.18632/oncotarget.299

Weibo Luo,  and Gregg L. Semenza
551-556
Abstract  |  PDF  |  HTML  |  Order a Reprint

Targeting cancer with peptide aptamers

Targeting cancer with peptide aptamers

https://doi.org/10.18632/oncotarget.297

Renaud Seigneuric, Jessica Gobbo, Pierre Colas,  and Carmen Garrido
557-561
Abstract  |  PDF  |  HTML  |  Order a Reprint

Targeting invadopodia to block breast cancer metastasis

Targeting invadopodia to block breast cancer metastasis

https://doi.org/10.18632/oncotarget.301

Mark A Eckert,  and Jing Yang
562-568
Abstract  |  PDF  |  HTML  |  Order a Reprint

Wnt and Kras signaling-dark siblings in lung cancer

Wnt and Kras signaling-dark siblings in lung cancer

https://doi.org/10.18632/oncotarget.305

Eugenia C. Pacheco-Pinedo,  and Edward E. Morrisey
569-574
Abstract  |  PDF  |  HTML  |  Order a Reprint

Evi1 forms a bridge between the epigenetic machinery and signaling pathways

Evi1 forms a bridge between the epigenetic machinery and signaling pathways

https://doi.org/10.18632/oncotarget.304

Akihide Yoshimi,  and Mineo Kurokawa
575-586
Abstract  |  PDF  |  HTML  |  Order a Reprint


Copyright © 2017 Impact Journals
Impact Journals is a registered trademark of Impact Journals, LLC